Novel Insights into Osteoarthritis, Pain and Function: MOST4
对骨关节炎、疼痛和功能的新见解:MOST4
基本信息
- 批准号:10555681
- 负责人:
- 金额:$ 1151.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse effectsAffectBathingBiological MarkersBiologyBiomechanicsCalciumChronicClinicalClinical DataClinical TrialsClinical Trials Data Monitoring CommitteesCommunitiesComplexCrystal FormationDataData CollectionDegenerative polyarthritisDepositionDeteriorationDiagnosticDiseaseDisease ProgressionElderlyEligibility DeterminationEnrollmentExerciseFrightGluesGoalsGrantHeterogeneityImageImpairmentInflammationInflammatoryInvestigationJointsK-Series Research Career ProgramsKneeKnee OsteoarthritisKnowledgeMagnetic Resonance ImagingMinority GroupsNervous SystemOutcomeOutputPainPain MeasurementPain managementParticipantPathologyPatient ParticipationPatientsPhenotypePhysical activityPilot ProjectsPreventionProteinsProteomicsPublishingRecommendationReplacement ArthroplastyResearch PersonnelRiskRisk FactorsSample SizeSignal TransductionSourceSynovial FluidTalentsUnderrepresented MinorityVisualizationWorkadvanced diseaseblood-based biomarkercareercareer developmentcohortdata managementdisabilitydisabling diseasedisorder preventioneffective therapyexperiencefallsfunctional declinefunctional outcomesindividualized preventioninsightinterdisciplinary approachknee painloss of functionmineralizationnovelnovel strategiesnovel therapeutic interventionpain sensitivitypersonalized approachpersonalized medicineprognosticradiological imagingreconstitutionrecruitresponsetherapeutic targettherapy developmenttreatment guidelines
项目摘要
OVERALL ABSTRACT
The Multicenter Osteoarthritis (MOST) Study has been a major source of new knowledge about the course of
OA and factors that affect it, having published over 180 articles ranging from studies of pain and pain
sensitization, to investigations of biomechanics, to inquiries into structural joint pathology as visualized by MRI,
and to studies of decline in function, buckling and falls, among others. The initial cohort enrolled 3026 participants
with or at risk of knee OA; a new cohort consisting of 1525 subjects was recruited at the last cycle (MOST3) who
were slightly younger and unlikely to have advanced disease. We will recruit an additional 150 participants from
underrepresented minority groups for a total projected sample size of 2293 in this next cycle of MOST (MOST4).
In addition to its scientific output, the study has been remarkable in recruiting and encouraging talented young
investigators to take on career defining investigations within MOST, having served as the basis for 31 career
development awards. Our overall goal is to advance our understanding of OA and its consequences to open
doors to new treatment approaches including stratified approaches to treatments. We will use an integrated
approach in the next cycle of MOST (MOST4) overseen by an Administrative Core, involving a Clinical Data
Collection and Management Core, Analysis Core, and Imaging Core, with guidance from an Observational Safety
Monitoring Board and input from a Community Advisory Board, to efficiently address key knowledge gaps
through the conduct of three Projects. Our Specific Aims are to: 1. Evaluate impaired exercise-induced
hypoalgesia (EIH) in knee OA, evaluate the relation of nervous system alterations to EIH, and determine the
impact of EIH on pain, function, physical activity, and fear-avoidance related to exercise (Project 1); 2. Carry out
proteomics analysis of synovial fluid to determine networks of proteins associated with generalized vs. localized
OA, pain and disease progression (Project 2); 3. Differentiate types of calcium crystals deposited in the joint and,
for each of them, understand the clinical and structural consequences of crystal deposition (Project 3); 4. Take
advantage of comprehensive longitudinal data already collected in MOST to address a wide range of questions
related to OA and its impact on outcomes; 5. Bring a multidisciplinary approach to bear on this complex disease
and offer career development opportunities to investigators including pilot project grants in this understudied
condition. MOST4 will introduce new approaches to understanding disease and will continue to comprehensively
assess pain, structural, and functional outcomes so that the specific effects of the factors proposed in the Projects
and other risk factors can be examined. This work will produce new actionable insights regarding pain, structural
deterioration and function loss in knee OA.
整体的抽象
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID Tobin FELSON其他文献
DAVID Tobin FELSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID Tobin FELSON', 18)}}的其他基金
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 1151.4万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 1151.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 1151.4万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 1151.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 1151.4万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 1151.4万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 1151.4万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 1151.4万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 1151.4万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 1151.4万 - 项目类别:
Studentship